As of 2025-05-16, the Fair Value of Armata Pharmaceuticals Inc (ARMP) is -2.61 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.40 USD, the upside of Armata Pharmaceuticals Inc is -286.67%.
With the market price of 1.40 USD and our fair value calculation, Armata Pharmaceuticals Inc (ARMP) is not a good investment. Investing in ARMP stocks now will result in a potential loss of 286.67%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -22.18 | -23.16 | -36.92 | -69.04 | -18.92 | -34.04 |
| YoY growth | -13.86% | -4.42% | -59.41% | -87.01% | 72.60% | -18.42% |
| Market Cap (mil) | 50.67 |
| P/E | |
| Forward P/E |
| EPS | -0.52 |
| Avg earnings growth rate | -18.42% |
| TTM earnings | -18.92 |